|
|
|
Volumn 28, Issue 4, 1996, Pages 2204-2206
|
|
Safety and tolerability of CyA microemulsion formulation (sandimmun neoral) in stable renal transplant patients after 24 months of treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CREATININE BLOOD LEVEL;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG FORMULATION;
DRUG SAFETY;
EDEMA;
EMULSION;
GASTROINTESTINAL SYMPTOM;
GINGIVA HYPERPLASIA;
GRAFT REJECTION;
HEADACHE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TREMOR;
ADMINISTRATION, ORAL;
CREATININE;
CYCLOSPORINE;
DOUBLE-BLIND METHOD;
EMULSIONS;
GINGIVA;
HUMANS;
HYPERPLASIA;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
TIME FACTORS;
UREA;
|
|
EID: 0029811729
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (12)
|
|
References (0)
|
